D-0091-2021 Class II Terminated
FDA drug recall D-0091-2021 was initiated by Milbar Laboratories, Inc. on October 9, 2020 and is designated Class II. Reason for recall: GMP Deviations The recall status is terminated (terminated January 4, 2023). Affected quantity: 2,655 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- November 25, 2020
- Initiation Date
- October 9, 2020
- Termination Date
- January 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,655 bottles
Product Description
MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles, MD Professional LLC, Minneapolis, MN
Reason for Recall
GMP Deviations
Distribution Pattern
Product was distributed throughout the United States, including Puerto Rico and internationally.
Code Information
Lot #: DX278, Exp. Date Apr-23